[go: up one dir, main page]

BR9916868A - Inaladores pressurizados com doses mensuradas (ipdm) - Google Patents

Inaladores pressurizados com doses mensuradas (ipdm)

Info

Publication number
BR9916868A
BR9916868A BR9916868-5A BR9916868A BR9916868A BR 9916868 A BR9916868 A BR 9916868A BR 9916868 A BR9916868 A BR 9916868A BR 9916868 A BR9916868 A BR 9916868A
Authority
BR
Brazil
Prior art keywords
ipdm
pressurized inhalers
measured doses
inhalers
pressurized
Prior art date
Application number
BR9916868-5A
Other languages
English (en)
Other versions
BR9916868B1 (pt
Inventor
David Lewis
Gaetano Brambilla
David Ganderton
Brian Meakin
Raffaella Garzia
Paolo Ventura
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26331622&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9916868(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from ITMI982559 external-priority patent/IT1303789B1/it
Priority claimed from IT1999MI001712 external-priority patent/IT1313582B1/it
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of BR9916868A publication Critical patent/BR9916868A/pt
Publication of BR9916868B1 publication Critical patent/BR9916868B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Application Of Or Painting With Fluid Materials (AREA)
  • Measurement Of Radiation (AREA)
  • Steroid Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

"INALADORES PRESSURIZADOS COM DOSES MENSURADAS (IPDM)". Esta invenção se refere ao uso de inaladores pressurizados com doses mensuradas (IPDMs) tendo parte das superfícies ou o todo de suas superfícies internas feitas de aço inoxidável, alumínio anodizado ou revestidas com uma camada orgânica inerte, e às composições a serem fomecidas com esses IPDMs.
BRPI9916868-5A 1998-11-25 1999-11-23 inaladores pressurizados com doses mensuradas (ipdm). BR9916868B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
ITMI982559 IT1303789B1 (it) 1998-11-25 1998-11-25 "inalatori dosati pressurizzati"
ITMI98A002559 1998-11-25
ITMI99A001712 1999-07-30
IT1999MI001712 IT1313582B1 (it) 1999-07-30 1999-07-30 Inalatori dosati pressurizzati.
PCT/EP1999/009002 WO2000030608A1 (en) 1998-11-25 1999-11-23 Pressurised metered dose inhalers (mdi)

Publications (2)

Publication Number Publication Date
BR9916868A true BR9916868A (pt) 2001-11-06
BR9916868B1 BR9916868B1 (pt) 2011-02-08

Family

ID=26331622

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9916868-5A BR9916868B1 (pt) 1998-11-25 1999-11-23 inaladores pressurizados com doses mensuradas (ipdm).

Country Status (36)

Country Link
US (8) US7347199B1 (pt)
EP (4) EP1131051B1 (pt)
JP (1) JP2002530156A (pt)
KR (1) KR100696746B1 (pt)
CN (1) CN1200690C (pt)
AR (1) AR021391A1 (pt)
AT (2) ATE485812T1 (pt)
AU (1) AU764696C (pt)
BG (1) BG65596B1 (pt)
BR (1) BR9916868B1 (pt)
CA (2) CA2698376A1 (pt)
CO (1) CO5170487A1 (pt)
CY (1) CY1105356T1 (pt)
CZ (1) CZ301305B6 (pt)
DE (3) DE69929358T2 (pt)
DK (1) DK1131051T3 (pt)
DZ (1) DZ2947A1 (pt)
EA (1) EA004132B1 (pt)
EE (1) EE04259B1 (pt)
EG (1) EG25278A (pt)
ES (1) ES2255767T3 (pt)
GE (1) GEP20033129B (pt)
HK (1) HK1040063B (pt)
HU (1) HU226735B1 (pt)
IL (3) IL143294A0 (pt)
MA (1) MA26764A1 (pt)
NO (1) NO330194B1 (pt)
NZ (2) NZ527190A (pt)
PL (2) PL200658B1 (pt)
SA (1) SA99200825B1 (pt)
SI (1) SI1131051T1 (pt)
SK (1) SK285246B6 (pt)
TN (1) TNSN99220A1 (pt)
TR (2) TR200704956T2 (pt)
TW (1) TWI226247B (pt)
WO (1) WO2000030608A1 (pt)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
SE9703407D0 (sv) 1997-09-19 1997-09-19 Astra Ab New use
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6739333B1 (en) 1999-05-26 2004-05-25 Boehringer Ingelheim Pharma Kg Stainless steel canister for propellant-driven metering aerosols
US6315985B1 (en) * 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317720B1 (it) * 2000-01-07 2003-07-15 Chiesi Farma Spa Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
US20060257324A1 (en) * 2000-05-22 2006-11-16 Chiesi Farmaceutici S.P.A. Pharmaceutical solution formulations for pressurised metered dose inhalers
CN1213732C (zh) 2000-05-22 2005-08-10 奇斯药制品公司 用于加压计量吸入器的稳定药用溶液制剂
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US20020085978A1 (en) * 2000-11-10 2002-07-04 Mina Buenafe Degradation-resistant glucocorticosteroid formulations
EP1241113A1 (en) * 2001-03-12 2002-09-18 CHIESI FARMACEUTICI S.p.A. Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein
GB0106046D0 (en) * 2001-03-12 2001-05-02 Glaxo Group Ltd Canister
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
EP1273292B1 (en) * 2001-07-02 2004-05-26 CHIESI FARMACEUTICI S.p.A. Optimised formulation of tobramycin for aerosolization
EP1321159A1 (en) 2001-12-21 2003-06-25 CHIESI FARMACEUTICI S.p.A. Pressurized metered dose inhaler (pMDI) actuators with laser drilled orifices
AU2003222753B2 (en) * 2002-03-01 2008-04-17 Chiesi Farmaceutici S.P.A. Formoterol superfine formulation
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
EP1415647A1 (en) * 2002-10-23 2004-05-06 CHIESI FARMACEUTICI S.p.A. "Long-acting beta-2 agonists ultrafine formulations"
US20040126325A1 (en) * 2002-03-12 2004-07-01 David Lewis Medicinal aerosol solution formulation products with improved chemical stability
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
AU2003293528A1 (en) * 2003-02-04 2004-09-06 Chrysalis Technologies Incorporated Perfluorocarbon and hydrofluorocarbon formulations and methods of making and using same
HRP20050822B1 (hr) 2003-03-20 2013-09-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulacija za inhalator s odmjerenom dozom koji koristi hidro-fluoro-alkane kao propelente
EP1915985A1 (en) 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
GB0311701D0 (en) * 2003-05-21 2003-06-25 Karib Kemi Pharm Liited Improved metered dose inhaler product
ATE494239T1 (de) 2003-06-24 2011-01-15 Cipla Ltd Vorrichtung zum abgeben von pharmazeutischen produkten
US7273603B2 (en) * 2003-07-11 2007-09-25 Boehringer Ingelheim International Gmbh HFC solution formulations containing an anticholinergic
DE10345065A1 (de) * 2003-09-26 2005-04-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
JP2007509147A (ja) * 2003-10-20 2007-04-12 シェーリング　コーポレイション 薬学的エアロゾル組成物
IL177103A0 (en) * 2004-02-27 2006-12-10 Chiesi Farma Spa Stable pharmaceutical solution formulations for pressurized metered dose inhalers
EP1595531A1 (en) * 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
CN100457087C (zh) * 2004-02-27 2009-02-04 奇斯药制品公司 用于加压计量吸入器的稳定的药用溶液制剂
MXPA06015204A (es) 2004-07-02 2007-03-15 Boehringer Ingelheim Int Formulaciones en suspension de aerosol con tg 227 ea o tg 134 a como agentes propulsores.
UA92732C2 (ru) 2005-02-25 2010-12-10 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Фармацевтические аэрозольные композиции для ингаляторов под давлением с вымеренными дозами, которые содержат связующее соединение
MX2007012084A (es) * 2005-03-30 2007-11-21 Schering Corp Medicamentos y metodos que combinan un anticolinergico, un corticosteroide y un agonista beta de accion prolongada.
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
US8227027B2 (en) 2007-12-07 2012-07-24 Presspart Gmbh & Co. Kg Method for applying a polymer coating to an internal surface of a container
JP5908884B2 (ja) 2010-03-15 2016-04-26 ヴァージニア コモンウェルス ユニヴァーシティＶｉｒｇｉｎｉａ Ｃｏｍｍｏｎｗｅａｌｔｈ Ｕｎｉｖｅｒｓｉｔｙ 気道炎症及び粘液線毛輸送機能異常治療用のエアロゾル化したダプソン
BR112013001119A2 (pt) * 2010-07-16 2016-05-24 Cipla Ltd composição farmacêutica, processo para fabricar uma composição farmacêutica, uso de r(+)budesonida e um broncodilatador, e método de profilaxia ou tratamento de uma doença respiratória, inflamatória ou obstrutiva das vias aéreas
TWI399202B (zh) 2011-03-17 2013-06-21 Intech Biopharm Ltd 製備用於治療呼吸道疾病之定量噴霧吸入劑的製程方法
GB201108039D0 (en) * 2011-05-13 2011-06-29 Mexichem Amanco Holding Sa Compositions
CN102379846B (zh) * 2011-10-21 2014-07-02 江苏长风药业有限公司 以氢氟烷烃和聚乙二醇为辅料氟替卡松丙酸酯气雾剂制剂
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
CN103207032A (zh) * 2012-01-13 2013-07-17 热敏碟公司 低型面温度传感器探针
KR101313993B1 (ko) * 2012-07-24 2013-10-01 한국화학연구원 약물 흡입 장치
DE102013214601B3 (de) 2013-07-25 2014-05-22 Aptar Radolfzell Gmbh Gehäuse für eine Inhalationsvorrichtung und Inhalationsvorrichtung zur oralen Verabreichung eines pharmazeutischen Mediums
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
EP3160445B1 (en) * 2014-06-26 2021-10-20 Island Breeze Systems Ca, LLC Mdi related products and methods of use
AU2015315351B2 (en) * 2014-09-08 2018-06-21 Becton, Dickinson And Company Enhanced platen for pharmaceutical compounding
CN106620976B (zh) * 2016-12-28 2020-01-07 四川普锐特医药科技有限责任公司 一种丙酸氟替卡松定量吸入气雾剂
US10231948B2 (en) 2017-02-27 2019-03-19 Jason Ty Nguyen Metered dose inhaler compositions, systems, and methods
US20210244896A1 (en) * 2018-06-13 2021-08-12 Puff-Ah Pty Ltd Apparatus for use in delivering respiratory drugs
EP4495192A1 (de) * 2023-07-18 2025-01-22 Colosol Coatings GmbH Beschichteter lackierträger, verfahren zur herstellung und verwendung des lackierträgers
WO2025128797A1 (en) 2023-12-13 2025-06-19 Blue Evolution, Inc Ecofriendly, biodegradable biological polysaccharide composition for packaging materials

Family Cites Families (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US154013A (en) * 1874-08-11 Improvement in carriage-lamps
US220718A (en) * 1879-10-21 Improvement in street-car warmers
BE555319A (pt) * 1956-03-21 1900-01-01
US3361306A (en) * 1966-03-31 1968-01-02 Merck & Co Inc Aerosol unit dispensing uniform amounts of a medically active ingredient
CA882187A (en) 1968-03-13 1971-09-28 Farbenfabriken Bayer Aktiengesellschaft Thermoplastic-elastic moulding compounds
US3622053A (en) * 1969-12-10 1971-11-23 Schering Corp Aerosol inhaler with flip-up nozzle
MX3864E (es) 1975-05-27 1981-08-26 Syntex Corp Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona
US4185100A (en) 1976-05-13 1980-01-22 Johnson & Johnson Topical anti-inflammatory drug therapy
US4499108A (en) 1983-06-08 1985-02-12 Schering Corporation Stable pleasant-tasting albuterol sulfate pharmaceutical formulations
GB8334494D0 (en) * 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
IT1196142B (it) * 1984-06-11 1988-11-10 Sicor Spa Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
US4584320A (en) * 1985-01-03 1986-04-22 David Rubin Anti-asthmatic composition and method using 8,11,14,17-eicosatetraenoic acid
US5192528A (en) 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5225183A (en) 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
IL97065A (en) 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
DE59104030D1 (de) 1990-02-14 1995-02-09 Systec Ausbausysteme Gmbh Transportwagen mit münzschloss.
IT1244441B (it) * 1990-09-13 1994-07-15 Chiesi Farma Spa Dispositivo per l'inalazione boccale di farmaci aerosol
WO1992011236A1 (en) 1990-12-19 1992-07-09 Smithkline Beecham Corporation Aerosol formulations
US6006745A (en) * 1990-12-21 1999-12-28 Minnesota Mining And Manufacturing Company Device for delivering an aerosol
US5190029A (en) * 1991-02-14 1993-03-02 Virginia Commonwealth University Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
EP0504112A3 (en) 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
JP3327546B2 (ja) 1991-05-21 2002-09-24 アボツト・ラボラトリーズ エアゾール吸入装置
PL169046B1 (pl) * 1991-08-29 1996-05-31 Christoph Klein Przyrzad medyczny do inhalacji aerozolem PL PL PL PL PL
NZ244439A (en) 1991-09-25 1994-01-26 Fisons Plc Pressurised aerosol compositions comprising hydrofluoroalkane, dispersed
US5219882A (en) 1991-10-24 1993-06-15 Emil Bisaccia Treatment methods for lymes disease and associated debilitating conditions
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
ES2159678T3 (es) 1991-12-18 2001-10-16 Minnesota Mining & Mfg Formulaciones de aerosol en suspension.
DE4230876A1 (de) 1992-03-17 1993-09-23 Asta Medica Ag Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
EP0673240B1 (en) 1992-12-09 1999-03-24 Boehringer Ingelheim Pharmaceuticals Inc. Stabilized medicinal aerosol solution formulations
SE9203743D0 (sv) 1992-12-11 1992-12-11 Astra Ab Efficient use
WO1994014490A1 (de) 1992-12-23 1994-07-07 Bernhard Hugemann Verfestigter arzneistoffvorrat für die mechanische erzeugung inhalierbarer wirkstoffpartikel
DE69413955T2 (de) 1993-03-17 1999-04-01 Minnesota Mining And Mfg. Co., Saint Paul, Minn. Aerosolzusammensetzung enthaltend einen aus ester-, amid- oder merkaptoester- derivat dispergiermittel
CA2156075C (en) 1993-03-17 2004-06-22 Daniel C. Duan Aerosol formulation containing a dispersing aid
US5899201A (en) * 1993-05-26 1999-05-04 Minnesota Mining And Manufacturing Company Aerosol actuator
US6596260B1 (en) 1993-08-27 2003-07-22 Novartis Corporation Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol
CA2178473C (en) * 1993-12-20 2004-08-24 Tsi-Zong Tzou Flunisolide aerosol formulations
US5508269A (en) * 1994-10-19 1996-04-16 Pathogenesis Corporation Aminoglycoside formulation for aerosolization
GB9425160D0 (en) 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
JP4155594B2 (ja) 1994-12-22 2008-09-24 アストラゼネカ・アクチエボラーグ エアゾール製剤
GB9426252D0 (en) 1994-12-24 1995-02-22 Glaxo Group Ltd Pharmaceutical composition
DE4446891A1 (de) 1994-12-27 1996-07-04 Falk Pharma Gmbh Stabile wäßrige Budesonid-Lösung
US5653961A (en) 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
DE69637257T2 (de) 1995-04-14 2008-06-12 Smithkline Beecham Corp. Verfahren zur Herstellung eines Dosierinhalators
PL180880B1 (pl) * 1995-04-14 2001-04-30 Glaxo Wellcome Inc Inhalator z dozymetrem
DE69634865D1 (de) 1995-04-14 2005-07-21 Smithkline Beecham Corp Dosierinhalator für Salmeterol
WO1996032151A1 (en) 1995-04-14 1996-10-17 Glaxo Wellcome Inc. Metered dose inhaler for fluticasone propionate
US5637505A (en) * 1995-05-19 1997-06-10 Chiron Diagnostics Corporation Method to prepare dye-based reference material
GB9526392D0 (en) * 1995-12-22 1996-02-21 Glaxo Group Ltd Medicaments
GB9612297D0 (en) 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
WO1998001147A1 (en) 1996-07-08 1998-01-15 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
WO1998003533A1 (en) 1996-07-24 1998-01-29 Oligos Etc. And Oligos Therapeutics, Inc. Antisense oligonucleotides as antibacterial agents
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
GB9620187D0 (en) 1996-09-27 1996-11-13 Minnesota Mining & Mfg Medicinal aerosol formulations
US6413496B1 (en) 1996-12-04 2002-07-02 Biogland Ireland (R&D) Limited Pharmaceutical compositions and devices for their administration
CA2273835A1 (en) * 1996-12-04 1998-06-11 Bioglan Ireland (R & D) Limited Pharmaceutical compositions and devices for their administration
AUPO429396A0 (en) * 1996-12-20 1997-01-23 Solsearch Pty Ltd Solar energy collector system
US6461591B1 (en) 1997-02-05 2002-10-08 Jago Research Ag Medical aerosol formulations
US6126919A (en) 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
US6129905A (en) * 1997-04-21 2000-10-10 Aeropharm Technology, Inc. Aerosol formulations containing a sugar as a dispersant
US5891419A (en) 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe flunisolide aerosol formulations for oral inhalation
US6488728B1 (en) 1997-06-12 2002-12-03 Pac Holdings S.A. Method for the disposal of waste products containing hydrocarbons and/or halogenated waste products
GB2326334A (en) 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
BR7702049U (pt) 1997-09-05 1999-09-14 Chiesi Farma Spa Bico pulverizador para utilização em inalador oral para medicamentos aerossóis
NZ504021A (en) 1997-10-17 2003-04-29 Systemic Pulmonary Delivery Lt Method and apparatus for delivering aerosolized medication having air discharged through air tube directly into plume of aerosolized medication
US6045784A (en) * 1998-05-07 2000-04-04 The Procter & Gamble Company Aerosol package compositions containing fluorinated hydrocarbon propellants
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
EP1087750B1 (en) 1998-06-18 2003-11-12 Boehringer Ingelheim Pharmaceuticals Inc. Pharmaceutical formulations for aerosols with two or more active substances
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6241969B1 (en) 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
US6585958B1 (en) 1998-07-24 2003-07-01 Jago Research Ag Medicinal aerosol formulations
DK1102579T3 (da) 1998-08-04 2003-07-14 Jago Res Ag Medicinske aerosolformuleringer
DK1121112T3 (da) 1998-10-17 2002-09-16 Boehringer Ingelheim Pharma Lagringsdygtigt koncentrat af aktivt stof med formoterol
DE19847969A1 (de) 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähig flüssige Formulierung mit Formoterol
US6086379A (en) * 1998-10-20 2000-07-11 Research Foundation Of State University Of New York System and method for training a swimmer
RU2221552C2 (ru) 1998-11-13 2004-01-20 Джаго Рисерч Аг Сухой порошок для ингаляции
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6290930B1 (en) 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
US6004537A (en) 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
WO2000053157A1 (en) 1999-03-05 2000-09-14 Chiesi Farmaceutici S.P.A. Improved powdery pharmaceutical compositions for inhalation
US6315985B1 (en) 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
WO2001047493A1 (en) 1999-12-24 2001-07-05 Glaxo Group Limited Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
CN1213732C (zh) * 2000-05-22 2005-08-10 奇斯药制品公司 用于加压计量吸入器的稳定药用溶液制剂
EP1273292B1 (en) * 2001-07-02 2004-05-26 CHIESI FARMACEUTICI S.p.A. Optimised formulation of tobramycin for aerosolization
EP1340492A1 (en) 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
EP1415647A1 (en) * 2002-10-23 2004-05-06 CHIESI FARMACEUTICI S.p.A. "Long-acting beta-2 agonists ultrafine formulations"
AU2003222753B2 (en) * 2002-03-01 2008-04-17 Chiesi Farmaceutici S.P.A. Formoterol superfine formulation
US6808684B2 (en) 2002-04-05 2004-10-26 International Flavors & Fragrance Inc. Fragrance material
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers

Also Published As

Publication number Publication date
GEP20033129B (en) 2003-12-25
SI1131051T1 (sl) 2006-04-30
EE200100276A (et) 2002-12-16
BG105532A (bg) 2001-12-29
SK7042001A3 (en) 2001-11-06
IL179491A0 (en) 2007-05-15
DZ2947A1 (fr) 2004-03-15
EP1523975B1 (en) 2010-10-27
US20030066525A1 (en) 2003-04-10
PL200658B1 (pl) 2009-01-30
BG65596B1 (bg) 2009-02-27
HK1040063B (en) 2006-04-21
CZ20011834A3 (cs) 2001-12-12
CN1200690C (zh) 2005-05-11
EP1523975A3 (en) 2005-08-31
US20050142071A1 (en) 2005-06-30
DE69942896D1 (de) 2010-12-09
AR021391A1 (es) 2002-07-17
AU764696C (en) 2004-06-24
MA26764A1 (fr) 2004-12-20
HUP0104411A2 (hu) 2002-03-28
JP2002530156A (ja) 2002-09-17
EE04259B1 (et) 2004-04-15
SA99200825B1 (ar) 2006-11-07
DE69929358T2 (de) 2006-07-13
AU1556300A (en) 2000-06-13
DK1131051T3 (da) 2006-04-18
PL348717A1 (en) 2002-06-03
NZ511926A (en) 2003-10-31
ATE485812T1 (de) 2010-11-15
NO20012516D0 (no) 2001-05-22
CA2352484A1 (en) 2000-06-02
KR100696746B1 (ko) 2007-03-19
CZ301305B6 (cs) 2010-01-06
TNSN99220A1 (fr) 2001-12-31
US20080115782A1 (en) 2008-05-22
US7347199B1 (en) 2008-03-25
EP1666029A1 (en) 2006-06-07
US7223381B2 (en) 2007-05-29
IL143294A0 (en) 2002-04-21
US20030089369A1 (en) 2003-05-15
CA2352484C (en) 2010-05-04
SK285246B6 (sk) 2006-09-07
HK1040063A1 (en) 2002-05-24
CY1105356T1 (el) 2010-03-03
DE69929358D1 (de) 2006-03-30
WO2000030608A1 (en) 2000-06-02
TWI226247B (en) 2005-01-11
CA2698376A1 (en) 2000-06-02
ES2255767T3 (es) 2006-07-01
BR9916868B1 (pt) 2011-02-08
HU226735B1 (en) 2009-08-28
TR200704956T2 (tr) 2008-01-21
US20040096399A1 (en) 2004-05-20
PL204572B1 (pl) 2010-01-29
ATE314838T1 (de) 2006-02-15
CO5170487A1 (es) 2002-06-27
HUP0104411A3 (en) 2002-12-28
EP1523975A2 (en) 2005-04-20
EG25278A (en) 2011-12-05
US8142763B2 (en) 2012-03-27
DE29923839U1 (de) 2001-03-01
US20110100361A1 (en) 2011-05-05
TR200101441T2 (tr) 2001-08-21
KR20010080543A (ko) 2001-08-22
NO20012516L (no) 2001-07-23
US20080247965A1 (en) 2008-10-09
EA200100468A1 (ru) 2001-12-24
US7740463B2 (en) 2010-06-22
NZ527190A (en) 2005-04-29
EP1674079A3 (en) 2006-07-05
EP1131051A1 (en) 2001-09-12
IL143294A (en) 2007-05-15
CN1328445A (zh) 2001-12-26
AU764696B2 (en) 2003-08-28
EP1674079A2 (en) 2006-06-28
NO330194B1 (no) 2011-03-07
EA004132B1 (ru) 2003-12-25
EP1131051B1 (en) 2006-01-04

Similar Documents

Publication Publication Date Title
BR9916868A (pt) Inaladores pressurizados com doses mensuradas (ipdm)
EA199700231A1 (ru) Дозирующий ингалятор для албутерола
BR0015884A (pt) Formulações de soluções farmacêuticas estáveis para inaladores de dose medida pressurizados
ATE204281T1 (de) Rapamycinamidinocarbamate und diese enthaltende pharmazeutische zubereitungen
BR0202436A (pt) Curativo adesivo com conforto e adesão aperfeiçoados durante o uso
BR0014399A (pt) Artigo absorvente com camada absorvente unitária para performance de enchimento do centro, e método de produçao do mesmo
FI962494A7 (fi) 5-(2-imidatsolinyyliamino)bentsimidatsolijohdannaisia, niiden valmistu s ja niiden käyttö alpha-2-adrenoseptoriagonisteina
BR9908766A (pt) Válvula para recipiente aerossol, recipiente aerossol e dispositivo de inalação
EE9700310A (et) N-propargüül-1-aminoindaani R-enantiomeeri, selle soolade ja kompositsioonide kasutamine
DE69930328D1 (de) Dimere Pyrrolobenzodiazepine
IT1224479B (it) Otturatore per protesi valvolari cardiache protesi valvolare cardiaca provvista di un tale otturatore e relativo procedimento di fabbricazione
DK1226387T3 (da) Aflang del med indbyrdes forbundne drejelige hjælpedele
DK0716605T3 (da) Blokering af aflejring af kim på humane celler
BR9307245A (pt) Conjunto de mancal fechado com rolete selado
BR0308762A (pt) Formulação farmacêutica compreendendo melatonina
BR0008139B1 (pt) composição lubrificante, e, uso de uma composição lubrificante.
IT1301679B1 (it) Derivati dell'iperforina, loro uso e formulazioni che licontengono.
TR199900124T2 (xx) Ha�ere �ld�r�c� bile�imler
ES2191206T3 (es) Nueva utilizacion de la creatina.
DE59108809D1 (de) 3-(Cis-3-Hexenyloxy)-propan-nitrile, dessen Herstellung und dessen Verwendung
BR9915835A (pt) Composição farmacêutica, e, processo para a preparação de uma composição
ES2179375T3 (es) Composiciones farmaceuticas estabilizadas, a base de quinupristina y de dalfopristina y su preparacion.
ES2014408B3 (es) Preparacion y procedimiento para el apresto de pieles y recubrimiento de textiles.
BR9810042A (pt) Pasta de fosqueamento para uso como um agente de fosqueamento em um sistema catiÈnico, e, sistema catiÈnico fotocurável
DE69521321D1 (de) Wässrige beschichtungszusammensetzung, ergebend beschichtungen mit verbesserter schnellhärte und klebfreiheit

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 9/12 (2008.01)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 08/02/2011, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time
B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)